Filing Flows

Filing Flows › Lemaitre Vascular (LMAT) › Q1 2026

Lemaitre Vascular (LMAT) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 6, 2026

Lemaitre Vascular (LMAT) reported revenue of $66.6M for the first quarter 2026 (Q1 2026), +11% from a year earlier and +3% from the quarter before. Operating margin was 26.7%, net earnings $15.7M (23.6% of revenue).

Revenue$66.6M
Year over year+11%
Quarter over quarter+3%
Operating margin26.7%
Net earnings$15.7M

Lemaitre Vascular, Q1 2026: revenue $66.6M (+11% year over year), operating margin 26.7%, net earnings $15.7M, operating cash flow $15.1M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$66.6M+3%+11%
Gross profit$48.4M+5%+17%
Operating profit$17.8M-6%+41%
Net earnings$15.7M+0.6%+42%
Operating cash flow$15.1M-35%+67%
Free cash flow$12.3M-42%+61%

What changed

Revenue was $66.6M in Q1 2026, up 11% year over year and up 3% from the previous quarter.

Gross margin was 72.7%, up 3.5 points from Q1 2025. Operating profit was $17.8M, a 26.7% margin (up 5.6 points year over year). Of the extra revenue versus Q1 2025, 77% reached operating profit, above the 21% margin then. Operating expenses grew 6% against revenue growth of 11%. The fastest-growing cost line was General & admin (+15%). Net earnings were $15.7M, up 42% year over year. The effective tax rate was 20.3%.

Operating cash flow was $15.1M (up 67% year over year), 96% of net earnings. Non-cash charges added back $2.6M of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items used $5.3M. Capital expenditures of $2.8M left free cash flow of $12.3M.

Questions

What was Lemaitre Vascular's revenue in the first quarter 2026?

Lemaitre Vascular (LMAT) reported revenue of $66.6M for the first quarter 2026 (Q1 2026), +11% from a year earlier and +3% from the quarter before.

Was Lemaitre Vascular profitable in the first quarter 2026?

Operating profit was $17.8M (26.7% of revenue) and net earnings $15.7M.

Open the interactive Sankey →

Source: Lemaitre Vascular 10-Q on SEC EDGAR.